Clinical Trial Update: A Study to Evaluate the Effects of Tyramine in Patients Who Completed the PRESTO Study. [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing the effects of tyramine in Parkinson's disease patients who completed the PRESTO study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Tyramine (tyramine)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Parkinson's Disease | Phase 3 | Status: COMPLETED